$HESM

Hess Midstream LP

11
5
12

No SEC Form 4 filings for $HESM in the last 30 days.

See all $HESM insider activity →

Hess Midstream LP (HESM): Entry into a Material Definitive Agreement

Hess Midstream LP (HESM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Hess Midstream LP Announces Transformative Transaction Leading to New Independent Multi-basin Midstream Company October 6, 2026 Highlights: • Hess Midstream LP and Chevron have executed a definitive agreement that will establish Hess Midstream LP as an independent, m

US Stocks Today: Top Gainers, Losers and Market Movers

Neogen (NEOG) reported Q1 FY27 revenue up 6.5% to $222.8M, raised full-year guidance, but shares fell 3.7%. Penguin Solutions (PENG) beat Q4 estimates, raised FY27 outlook, shares up 13.9%. Constellation Brands (STZ) topped Q2 estimates, shares up 3.5%. Hess Midstream (HESM) shares dropped 10.3% after restructuring deal with Chevron (CVX) and lowered 2027 outlook. SRX Global (SRXH) shares rose 4% after $1M stock deal to acquire CERo Therapeutics.

HESM sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 28 news stories mentioning HESM (Hess Midstream LP). Coverage has skewed bearish: 11 bullish, 5 neutral, and 12 bearish.

Recent HESM coverage spans mergers & acquisitions, corporate actions and market movers.

What's driving HESM

AlphAI scores every news story that mentions HESM with an AI model for sentiment and relevance, and aggregates insider trades from Hess Midstream LP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HESM

Score
$HESMHigh

Hess Midstream LP (HESM): Entry into a Material Definitive Agreement

Hess Midstream LP (HESM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Hess Midstream LP Announces Transformative Transaction Leading to New Independent Multi-basin Midstream Company October 6, 2026 Highlights: • Hess Midstream LP and Chevron have executed a definitive agreement that will establish Hess Midstream LP as an independent, m

$NEOGMed

US Stocks Today: Top Gainers, Losers and Market Movers

Neogen (NEOG) reported Q1 FY27 revenue up 6.5% to $222.8M, raised full-year guidance, but shares fell 3.7%. Penguin Solutions (PENG) beat Q4 estimates, raised FY27 outlook, shares up 13.9%. Constellation Brands (STZ) topped Q2 estimates, shares up 3.5%. Hess Midstream (HESM) shares dropped 10.3% after restructuring deal with Chevron (CVX) and lowered 2027 outlook. SRX Global (SRXH) shares rose 4% after $1M stock deal to acquire CERo Therapeutics.

Market movers: Constellation Brands, Webull, FuelCell, Sigma

FuelCell Energy (FCEL) shares dropped 15% after announcing a CFO transition. Ondas (ONDS) fell 5% despite $165M in new orders. Ultragenyx (RARE) rose 3.2% after selling a priority review voucher for $210M. TNR Gold (TNR) received an acquisition proposal from Altius (ALS). Rocket Pharma (RCKT) gained 4% after securing a $150M credit facility. Sigma Lithium (SGML) resumed operations after court approval. Hess Midstream (HESM) fell 16% after Chevron deal.

US PRE-MARKET MOVERS: Mag-7, INTC, STZ, UAA, HESM, SPCX, ZIM, BKH, BULL, NEOG

In US pre-market trading, most Mag-7 stocks fell while Apple rose 0.5%. Intel gained 0.5% on comments about Musk’s Terafab venture. Constellation Brands fell 6% on a light profit outlook and softer beer demand. Under Armour rose 1% after Frasers Group built an 8.8% stake. Hess Midstream fell 2% as Chevron planned to divest its interests and Hess Midstream cut its outlook. SPCX fell 2.5% while seeking USD 40bln in financing; ZIM gained 4.5% after raising guidance.

Hess Midstream (HESM) cuts FY26 outlook with net seen at USD 650mln-675mln (prev. 650mln-700mln), Adj. EBITDA seen at USD 1.23bln-1.25bln (prev. 1.23bln-1.28bln), sees FY27 Adj. EBITDA USD 850mln-950mln

Hess Midstream cut its FY26 net income outlook to USD 650mln-675mln from USD 650mln-700mln and adjusted EBITDA to USD 1.23bln-1.25bln from USD 1.23bln-1.28bln. It sees FY27 adjusted EBITDA of USD 850mln-950mln. Hess Midstream and Chevron plan to amend Bakken agreements, reduce tariffs and extend the terms through 2045.

Related tickers